These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3543903)

  • 1. Current issues in transfusion therapy. 2. Indications for use of blood components.
    Coffin CM
    Postgrad Med; 1987 Jan; 81(1):343-6, 348-50. PubMed ID: 3543903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects of therapy with blood and blood components].
    Frick U; Frick G
    Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood component therapy (author's transl)].
    Kretschmer V
    Anasth Intensivther Notfallmed; 1980 Jun; 15(3):189-200. PubMed ID: 7468950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and abuse of blood.
    Hollán SR
    Ann Acad Med Singap; 1984 Jul; 13(3):502-9. PubMed ID: 6440468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation.
    Frenette L; Cox J; McArdle P; Eckhoff D; Bynon S
    Anesth Analg; 1998 Jun; 86(6):1183-6. PubMed ID: 9620500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric transfusion: considerations by age and blood component.
    Glassman AB
    South Med J; 1982 Jun; 75(6):722-5. PubMed ID: 6806910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical management of major blood loss.
    Gill R
    Anaesthesia; 2015 Jan; 70 Suppl 1():54-7, e19-20. PubMed ID: 25440396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital.
    Metz J; McGrath KM; Copperchini ML; Haeusler M; Haysom HE; Gibson PR; Millar RJ; Babarczy A; Ferris L; Grigg AP
    Med J Aust; 1995 Jun; 162(11):572-3, 576-7. PubMed ID: 7791642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of transfusion medicine].
    Höcker P
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):163-9. PubMed ID: 2866159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
    Görlinger K; Dirkmann D; Hanke AA; Kamler M; Kottenberg E; Thielmann M; Jakob H; Peters J
    Anesthesiology; 2011 Dec; 115(6):1179-91. PubMed ID: 21970887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The potentials of current transfusion hematology for component therapy with thrombocytes, granulocytes, plasma and plasma factors in obstetrics and gynecology].
    Nikolov A; Kovachev I; Gŭrcheva L; Dimitrov A
    Akush Ginekol (Sofiia); 1998; 37(4):50-2. PubMed ID: 10360056
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood cell substitution within the scope of hematologic intensive therapy for supportive hemotherapy with erythrocyte, thrombocyte and granulocyte concentrates].
    Helbig W; Kubel M
    Z Gesamte Inn Med; 1988 Oct; 43(20):561-6. PubMed ID: 3062934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substitution and protective therapy with blood components].
    Dietzfelbinger H; Woitinas F
    Med Klin; 1979 May; 74(18):680-5. PubMed ID: 431481
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy with blood components (author's transl)].
    Woitinas F; Dietzfelbinger H
    MMW Munch Med Wochenschr; 1981 Feb; 123(6):211-5. PubMed ID: 6782463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusion reactions.
    Shafer N; Wilkenfeld M; Shafer R
    Leg Med; 1980; ():207-20. PubMed ID: 7421388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood loss and transfusion requirements in liver transplantation: experience with the first 75 cases.
    McNicol PL; Liu G; Harley ID; McCall PR; Przybylowski GM; Bowkett J; Angus PW; Hardy KJ; Jones RM
    Anaesth Intensive Care; 1994 Dec; 22(6):666-71. PubMed ID: 7892969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)].
    Höcker P; Pittermann E; Mann M; Krasa E
    Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mode of preparation of labile blood products--available products].
    Lapierre V; Hervé P
    Presse Med; 1999 Jul 3-10; 28(24):1314-20. PubMed ID: 10442066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications of blood components and outcome of transfusion practices in hemorrhage of multiple trauma].
    Audibert G
    Cah Anesthesiol; 1994; 42(3):391-4. PubMed ID: 7812868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.